These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11288964)

  • 1. Rescue use of abciximab improves regional left ventricular function after early incomplete reperfusion in acute myocardial infarction.
    Cho GY; Lee CW; Hong MK; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    Clin Cardiol; 2001 Mar; 24(3):197-201. PubMed ID: 11288964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
    Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
    J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.
    Neumann FJ; Blasini R; Schmitt C; Alt E; Dirschinger J; Gawaz M; Kastrati A; Schömig A
    Circulation; 1998 Dec; 98(24):2695-701. PubMed ID: 9851955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abciximab improves 6-month clinical outcome after rescue coronary angioplasty.
    Petronio AS; Musumeci G; Limbruno U; De Carlo M; Baglini R; Paterni G; Grazia Delle Donne M; Caravelli P; Nardi C; Mariani M
    Am Heart J; 2002 Feb; 143(2):334-41. PubMed ID: 11835040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study.
    Rakowski T; Zalewski J; Legutko J; Bartus S; Rzeszutko L; Dziewierz A; Sorysz D; Bryniarski L; Zmudka K; Kaluza GL; Dubiel JS; Dudek D
    Am Heart J; 2007 Mar; 153(3):360-5. PubMed ID: 17307412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
    Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function.
    Danzi GB; Sesana M; Capuano C; Mauri L; Berra Centurini P; Baglini R
    Am J Cardiol; 2004 Jul; 94(1):35-9. PubMed ID: 15219505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Leoncini M; Toso A; Dabizzi RP
    Int J Cardiol; 2006 Mar; 108(1):36-42. PubMed ID: 15927285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.
    Di Pasquale P; Cannizzaro S; Scalzo S; Maringhini G; Vitrano GM; Giubilato A; Giambanco F; Sarullo FM; Paterna S
    Int J Cardiol; 2003 Dec; 92(2-3):265-70. PubMed ID: 14659863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
    Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN
    J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty.
    Petronio AS; Rovai D; Musumeci G; Baglini R; Nardi C; Limbruno U; Palagi C; Volterrani D; Mariani M
    Eur Heart J; 2003 Jan; 24(1):67-76. PubMed ID: 12559938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours.
    Maioli M; Gallopin M; Leoncini M; Bellandi F; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):484-91. PubMed ID: 15973688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
    Montalescot G; Barragan P; Wittenberg O; Ecollan P; Elhadad S; Villain P; Boulenc JM; Morice MC; Maillard L; Pansiéri M; Choussat R; Pinton P;
    N Engl J Med; 2001 Jun; 344(25):1895-903. PubMed ID: 11419426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.
    Costantini CO; Stone GW; Mehran R; Aymong E; Grines CL; Cox DA; Stuckey T; Turco M; Gersh BJ; Tcheng JE; Garcia E; Griffin JJ; Guagliumi G; Leon MB; Lansky AJ
    J Am Coll Cardiol; 2004 Jul; 44(2):305-12. PubMed ID: 15261923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy.
    Wöhrle J; Merkle N; Kunze M; Cristea E; Mehran R; Rottbauer W; Stone GW
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1083-9. PubMed ID: 22162175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial.
    Svensson L; Aasa M; Dellborg M; Gibson CM; Kirtane A; Herlitz J; Ohlsson A; Karlsson T; Grip L
    Am Heart J; 2006 Apr; 151(4):798.e1-7. PubMed ID: 16569536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction.
    Lee CW; Park SW; Cho GY; Hong MK; Kim JJ; Kang DH; Song JK; Lee HJ; Park SJ
    J Am Coll Cardiol; 2000 Mar; 35(4):949-55. PubMed ID: 10732893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre-hospitalization treatment with Abciximab in the preparation of patients for primary angioplasty in the acute phase of myocardial infarct. Immediate and long-term (one month) results].
    Glatt B; Luycx-Bore A; Guyon P; Chevalier B; Jullien T; Royer T; Hénequin B; Herlin C; Belotte F; Sebbah JL
    Arch Mal Coeur Vaiss; 1999 Oct; 92(10):1301-8. PubMed ID: 10562900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.